Medical Device News Magazine

Zeus Releases StreamLiner OTW

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

By extruding over wire, Zeus has produced the desired combination of wall thickness, flexibility, and strength. Zeus’ StreamLiner OTW products allow medical device manufacturers to develop safer, smoother and stronger catheters that can navigate deeper into a patient’s vasculature.

With the release of StreamLiner OTW, Zeus offers medical device manufacturers several advantages:

  • A product with a similar wall thickness and the flexibility of film cast PTFE liners but with greater strength.
  • Shorter lead times to speed time-to-market and reduce operational costs. Zeus’ in-house wire drawing capabilities increase wire availability, reduce turnaround times and shorten delivery schedules.
  • Simplified production processes. Zeus supplies straight, cut-to-length liners that allow you to take the product from packaging to production and eliminate multiple timely processes.

Specific catheter applications for the StreamLiner OTW family include occlusion balloon catheters, microcatheters, mechanical and aspiration thrombectomy catheters, intermediate catheters, guiding catheters with and without balloons, and support catheters.

COMMENTS

“Zeus continues to lead with its technological innovations in PTFE liners. Using a state-of-the-art process, our new StreamLiner OTW lineup opens the doors to new possibilities for catheter manufacturers. Currently, no other polymer solution provider can supply an extruded PTFE liner with comparable wall thickness, flexibility and strength. Zeus is the only company in the market capable of delivering flexible PTFE liners extruded over wire with the lowest wall thickness.” Bob Chaney, Senior Vice President, Global Sales & Marketing, Zeus Industrial Products, Inc.

“StreamLiner OTW bridges the gap between film cast liners and free extruded liners by providing extremely thin walls, flexibility, and strength. These features enable more catheter design options, which ultimately translates to better tractability, deliverability and overall performance – all without compromising patient safety.” Matt Allen, Senior Product Line Manager, Zeus Industrial Products, Inc.

QUICK FACTS

  • Zeus has launched StreamLiner OTW, a new product lineup within its StreamLiner™ family of thin, extruded PTFE catheter liners.
  • StreamLiner OTW uses a proprietary process that extrudes PTFE liners over-the-wire in a range of sizes with comparable wall thickness and flexibility to film cast tubing, but with greater strength.
  • The new product lineup offers nominal wall thicknesses as low as 0.0004″.
  • The new liners are provided in discrete straight lengths over silver-plated copper.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”